Allergan (NYSE:AGN) reported Q4 EPS of $1.00, inline with estimates. Revenues came in at $1.4 billion, which was also inline with estimates as well.Allergan said it sees 2012 EPS of $4.13 – $4.19, vs. estimates of $4.21.The company sees Q1 EPS of $0.84 – $0.86, vs. estimates of $0.91 and said it sees 2012 product sales of $5.65 billion – $5.85 billion, vs. estimates of $5.89 billion.